These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. MAO inhibitory side effects of neuroleptics and platelet serotonin content in schizophrenic patients. Mészáros Z; Borcsiczky D; Máté M; Tarcali J; Tekes K; Magyar K J Neural Transm Suppl; 1998; 52():79-85. PubMed ID: 9564610 [TBL] [Abstract][Full Text] [Related]
7. Relationship of auditory hallucinations and paranoia to platelet MAO activity in schizophrenics: sex and race interactions. Meltzer HY; Zureick JL Psychiatry Res; 1987 Oct; 22(2):99-109. PubMed ID: 3685225 [TBL] [Abstract][Full Text] [Related]
8. Monoamine oxidase activity and enzyme kinetics in three subpopulations of density-fractionated platelets in chronic paranoid schizophrenics. Mann JJ; Kaplan RD; Georgotas A; Friedman E; Branchey M; Gershon S Psychopharmacology (Berl); 1981; 74(4):344-8. PubMed ID: 6794079 [TBL] [Abstract][Full Text] [Related]
10. Platelet MAO activity in hallucinating and paranoid schizophrenics: a review and meta-analysis. Zureick JL; Meltzer HY Biol Psychiatry; 1988 May; 24(1):63-78. PubMed ID: 3285902 [TBL] [Abstract][Full Text] [Related]
11. Platelet monoamine oxidase and clinical phenomenology of schizophrenia. Baron M; Gruen R; Levitt M; Kane J Psychiatry Res; 1984 Mar; 11(3):205-9. PubMed ID: 6587413 [TBL] [Abstract][Full Text] [Related]
12. Kinetic constants of platelet monoamine oxidase in schizophrenia. Jackman HL; Meltzer HY Am J Psychiatry; 1983 Aug; 140(8):1044-7. PubMed ID: 6869590 [TBL] [Abstract][Full Text] [Related]